Performance and Safety of Lubri-cream for Pain Minimization During Urethral Catheterization and Cystoscopy
Launched by B. BRAUN MEDICAL SA · Oct 20, 2023
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a product called Lubri-cream, which is designed to help reduce pain during procedures that involve inserting a tube into the urethra, such as catheterization and cystoscopy. The goal is to see how well Lubri-cream works in real-life medical settings and to check if it's safe for patients.
To participate in this trial, you need to be at least 18 years old and require either urethral catheterization or cystoscopy. Participants will give their informed consent, meaning they understand the study and agree to join. However, if you have certain health conditions or are already part of another similar study, you may not be eligible. Since the trial is not yet recruiting, you’ll have a chance to learn more details before deciding to join if you qualify.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Any patient who needs urethral catheterization or cystoscopy (rigid or flexible).
- • Signed informed consent
- Exclusion Criteria:
- • Contraindications as stated in the Instructions for Use
- • Any medical or psychological disorder that, in the investigator's opinion, may interfere with the patient's ability to give informed consent and comply with the study procedures
- • Inclusion in another investigational study in the field of urethral catheterization or cystoscopy which could interfere with the clinical practice regarding the application and care of the Investigational Product.
About B. Braun Medical Sa
B. Braun Medical SA is a global leader in healthcare solutions, specializing in the development and manufacturing of innovative medical devices, pharmaceuticals, and services to enhance patient care. With a strong commitment to improving clinical outcomes and patient safety, B. Braun operates across various therapeutic areas, including anesthesia, surgery, and critical care. The company is dedicated to advancing medical technology through rigorous research and development, ensuring compliance with the highest regulatory standards. By fostering collaboration with healthcare professionals and institutions, B. Braun aims to address the evolving needs of the healthcare sector while maintaining a focus on sustainability and ethical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Anna Maria Martínez, Dr.
Principal Investigator
Hospital Universitari Mútua Terrassa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported